23 May 2023, PHILIPPINES – QIAGEN, a world-renowned leader in sample and assay technologies, is thrilled to announce the renaming of its Philippine-based Business Services entity from QIAGEN Business Services (Manila), Inc. to QIAGEN Manila. The renaming event took place on May 22, 2023, at the QIAGEN Manila office, Cyber Sigma Building, Taguig City, and marked a significant milestone in QIAGEN’s…

Technological advancements, the launch of various products, and strategies among key players such as acquisition, collaboration, and agreement serve as potential opportunities for the expansion of the global solid tumor testing market. The pandemic negatively altered the way cancer patients are being diagnosed and treated in the near term. Based on region, North America held the largest share in 2021, contributing to around two-fifths of the global solid tumor testing market share.

A new business intelligence report released by Allied Market Research, the global Solid Tumor Testing Market garnered $23.8 billion in 2021, and is estimated to generate $46.7 billion by 2031, manifesting a CAGR of 7.0% from 2022 to 2031.

2023: objetivo dividendo ¿en Diasorin y Quiagen?

En la carrera por buscar opciones atractivas en un mercado bursátil que sigue muy complicado pese a los rebotes puntuales, los expertos de Berenberg identifican el sector “que está llamado a ser el refugio perfecto”. Se trata del mercado del diagnóstico in vitro (DIV), que ofrece unos fundamentos de inversión “cada vez más atractivos en un contexto de incertidumbre económica”. Sobre DiaSorin,…

Global Enzyme Immunoassay (EIA) Reagents and Devices Market Synopsis:

The top-notch Enzyme Immunoassay (EIA) Reagents and Devices Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report acts upon Market study and analysis to provide Market data by considering new product development from beginning to launch. The key research methodology employed throughout this report by DBMR research team is data triangulation which entails data mining, analysis of the impact of data variables on the Market, and primary validation. Adopting Enzyme Immunoassay (EIA) Reagents and Devices Market report is always beneficial for any company, whether it is small scale or large scale, for Marketing its products or services.

SWOT analysis has been performed while creating Enzyme Immunoassay (EIA) Reagents and Devices Market document along with many other standard steps of researching, analysing and collecting data. The report is formulated by considering several steps which can be summarised as follows. 1. Craft a title page 2. Fix a table of contents 3. Edit the report in the executive summary 4. Inscribe an introduction 5. Write the qualitative research segment of the body 6. Note down the survey research section of the body 7. Go over the types of data used in drawing conclusions 8. Allocate findings based on research 9. State conclusions and call the reader to action.

Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-enzyme-immunoassay-eia-reagents-and-devices-market .

The Global Enzyme Immunoassay (EIA) Reagents and Devices Market will exhibit a CAGR of around 3.63% for the forecast period of 2021-2028.

According to market research study, Enzyme immunoassay (EIA) reagents and devices are used to detect the presence or concentration of an antigen with its application to epidemiological diseases detection. It includes different types of enzymes such as alkaline phosphatases and glucose oxidase. The devices are fragmented on the basis of technology and are used for a wide range of applications such as oncology, endocrinology, autoimmunity, toxicology, haematology, neonatal screening, and others.

The most significant key factors driving the growth of the Global Enzyme Immunoassay (EIA) Reagents and Devices Market are rising prevalence of chronic and infectious diseases coupled with rising geriatric population, rising research and developmental proficiencies by the pharmaceutical companies in order to come up with innovative drugs and healthcare technologies.

The major players covered in the Enzyme Immunoassay (EIA) Reagents And Devices Market report are Thermo Fisher Scientific Inc., BD, QIAGEN, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Hologic, Inc., Abbott, DSM, DuPont, bioMerieux SA, Promega Corporation., Siemens Healthcare Private Limited, Danaher., Sartorius AG, Sysmex Corporation, Phoenix Pharmaceuticals, DiaSorin S.p.A. and Merck KGaA among other domestic and global players.

Regionally, North America dominates the enzyme immunoassay (EIA) reagents and devices market is expected to continue its dominant trend during the forecast period. This is because of the increased focus to develop novel drugs and biomarkers for various kinds of diseases. Supportive government funding will also propel the growth of enzyme immunoassay (EIA) reagents and devices market in this region. APAC on the other hand will dominate in terms of highest CAGR during the forecast period owing to the increased public and private investment into enzyme immunoassay (EIA) reagents and devices. Rising prevalence of chronic and infectious diseases will further propel the market growth.

Global Cell Separation Technology Market Overview:

The market dynamics study of an influential Cell Separation Technology Market report demonstrates the scope of the various commercial possibilities over the coming years and the positive revenue forecasts in the years ahead. Important industry trends, market size, market share estimates are analysed and mentioned in the industry analysis report. It also studies the key markets and mentions the different regions i.e. the topographical spread of the business. The report gives helpful insights which assist while launching a new product. The large scale Cell Separation Technology market report helps business in knowing its market share over various time periods, transportation, storage, and supply requirements of its products.

The Global Cell Separation Technology Market to account to USD 26.12 Billion by 2028 and will grow at a CAGR of 17.01% in the forecast period of 2021 to 2028.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cell-separation-technology-market&paragp .

According to the market report analysis, Cell Separation Technology is used to separate cells from group of various cells. The separations of cells are based on their physical properties such as size, shape and protein expression.  Cell separation techniques play an essential role in the treatment of chronic diseases, such as cancer and AIDS.

The major key factors driving the growth of the Global Cell Separation Technology Market are rapid rise in the cell therapy based research activities, the improving healthcare infrastructure and the rise in the prevalence of chronic diseases, increase in the geriatric population and rapid surge in the investments in research and development. Additionally, the rise in the prevalence of cancer across the globe and increase in the number of neurodegenerative diseases are also amongst the significant factors expected to fuel the growth of the Cell Separation Technology Market.      

Top Leading Key in Players Global Cell Separation Technology Market: Terumo Corporation, STEMCELL Technologies Inc., pluriSelect Life Science UG & Co. KG, Miltenyi Biotec, Merck KGaA, Akadeum Life Sciences, Thermo Fisher Scientific Inc., BD, Bio-Rad Laboratories, Inc., Carl Zeiss AG, General Electric, QIAGEN, IBA Lifesciences GmbH, Elveflow, MPR Associates, Inc., PerkinElmer Inc., 10x Genomics, and ANGLE plc and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

In terms of the geographic analysis, North America region leads the Cell Separation Technology Market owing to the rapid technological advancements, strong presence of key players and rise in the awareness about cells separation technologies. APAC is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the rise in the medical tourism, developing healthcare infrastructure and increase in investments in healthcare.

Overview of the Middle East and Africa Cancer Spit Test Device Market:

Cancer Spit Test Device Market research report has been created with the systematic gathering and evaluation of market information for Healthcare industry which is presented in a form that explains various facts and figures to the business. This market survey document contains thorough analysis of market and numerous related factors that range from market drivers, market restraints, market segmentation, opportunities, challenges, and market revenues to competitive analysis. It lends a hand to companies in taking decisive actions to deal with threats in niche market. A brilliant team of analysts, experts, statisticians, forecasters and economists has worked rigorously to generate advanced and all-inclusive Cancer Spit Test Device Market report.

The Middle East and Africa Cancer Spit Test Device Market is growing with a CAGR of 7.8% in the forecast period of 2021 to 2028 and is expected to reach USD 34.95 Million by 2028 from USD 19.93 Million in 2020.

Get a Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=middle-east-and-africa-cancer-spit-test-device-market .

The most important key factors driving the growth of the Middle East and Africa Cancer Spit Test Device Market are increasing prevalence of chronic diseases and rapid growth in the number of cancer patients. Cancer saliva would test for the presence or absence of mutated extra-cellular DNA and RNA. The tumor cells shed DNA and RNA into the circulation and they come into saliva, and mutations are detectable with great accuracy in saliva.

According to the regional analysis, Countries covered in the Middle East and Africa Cancer Spit Test Device Market report are South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa. South Africa is expected to dominate the market due to increasing incidences of chronic diseases in the Middle East & Africa region.

The major players covered in the Middle East and Africa Cancer Spit Test Device Market report are DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG,  Miraclean Technology Co., Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific, Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd,  Oasis Diagnostics Corporation, and Canvax among other domestic and Middle East & Africa players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

A reliable Cancer Spit Test Device Market research report is one of the key factors used in maintaining competitiveness over competitors. For market segmentation study conducted in this business report, a market of potential customers is divided into groups or segments based on different characteristics such as application of product, deployment model, end user and geographical region etc. The business report also comprises of reviews about key players, major collaborations, merger & acquisitions along with trending innovation and business policies. Middle East and Africa Cancer Spit Test Device Market report brings together precise and accurate market research information that drives business into the right direction.

Europe Cancer Spit Test Device Market Overview:

The Europe Cancer Spit Test Device Market is growing with a CAGR of 9.3% in the forecast period of 2021 to 2028 and is expected to reach USD 224.29 Million by 2028 from USD 115.22 Million in 2020.

The top-notch Cancer Spit Test Device Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The marketing report acts upon market study and analysis to provide market data by considering new product development from beginning to launch. The key research methodology employed throughout this report by DBMR research team is data triangulation which entails data mining, analysis of the impact of data variables on the market, and primary validation. Adopting Cancer Spit Test Device Market report is always beneficial for any company, whether it is small scale or large scale, for marketing its products or services.

Available Exclusive Sample Copy of this Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=europe-cancer-spit-test-device-market .

Major key factors driving the growth of the Europe Cancer Spit Test Device Market are increasing prevalence of chronic diseases and rapid growth in the number of cancer patients. A saliva test is nowadays extensively used for cancer detection. Cancer saliva would test for the presence or absence of mutated extra-cellular DNA and RNA. The cancer saliva test devices market comprises testing kits, swabs, cassettes, and devices used for the detection of drugs, infections, or diseases in human beings.

Top Leading Key in Players Europe Cancer Spit Test Device Market: DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG,  Miraclean Technology Co., Ltd.,  Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd,  Oasis Diagnostics Corporation, and Canvax and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.

In terms of the geographic analysis, Countries covered in the Europe cancer spit test device market report are Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Sweden, Belgium, Estonia, and Rest of Europe. The market in Europe is expected to grow significantly in the forecast period of 2021 to 2028 due to increasing technological advancements in the region. Germany is dominating the European market owing to growing presence of key players in the market.